References
- Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group [see comments]. JAMA. 1998; 280(7)605–13
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.
- Patterns of use of hormone replacement therapy in one million women in Britain, 1996–2000. BJOG. 2002;109(12):1319–30.
- Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol. 1997; 145(6)536–45
- Hundrup YA, Obel EB, Rasmussen NK, Philip J. Use of hormone replacement therapy among Danish nurses in 1993. Acta Obstet Gynecol Scand. 2000; 79(3)194–201
- Bakken K, Eggen AE, Lund E. Hormone replacement therapy in Norwegian women, 1996–1997. Maturitas. 2001; 40(2)131–41
- Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal Hormone Replacement Therapy after the publication of clinical trial results. Ann Intern Med. 2004; 140(3)184–8
- Lokkegaard EL, Johnsen SP, Heitmann BL, Stahlberg C, Pedersen AT, Obel EB, et al. The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand. 2004; 83(5)476–81